BuyDideoxyinosine (didanosine) Powder Raw APIS Antiretroviral Drug For Human Immunodeficiency Virus Infections Online CAS 890-38-0
Dideoxyinosine Specification
| Item |
Specifications |
| Identincation |
A: IR comparison didanosine CRS |
| B:HPLC
Should meet the requirement |
| Water(K.F) |
≤2.0% |
| Residue on ignition |
≤0.2% |
| Heavy Metals |
≤20ppm |
| Specific Optical rotation |
-24.0°~-28.0°(anhydrous) |
| Related substances |
Hypoxanthine≤0.5% |
| Inosine≤0.2% |
| 2’-Deoxyinosine≤0.3% |
| 3’-Deoxyinosine≤0.2% |
| 2’,3’-anhydroinosine≤0.2% |
| Dideoxydidehydroinosine≤0.2% |
| 2’,3’-dideoxyadenosine≤0.2% |
| 5’-Deoxydideoxyadenosine≤0.2% |
| Any other impurity ≤0.1% |
| total≤1.0% |
| Assay (on the anhydrous basis) |
98.0%~102.0% |
What is Dideoxyinosine?
Dideoxyinosine is an antiretroviral drug used in the treatment of human immunodeficiency virus infections. ddI inhibits the enzyme reverse transcriptase, thereby restricting viral replication activity. Inside the body, ddI is converted to dideoxyadenosine, which becomes incorporated into the deoxyribonucleic acid chain, interrupting its normal sequence and making viral replication impossible. Also called didanosine.
Dideoxyinosine Application
Didanosine is used to treat HIV and AIDS. The medication has been approved for use in treating adults and children as young as two weeks old. Didanosine is not a cure for HIV or AIDS, but it can stop the HIV virus from multiplying and destroying healthy cells. Off-label didanosine uses include preventing HIV infection in people who have been exposed to the HIV viru
